Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025)
Akari Therapeutics (AKTX) posted Interest & Investment Income of $1000.0 for Q3 2025, little changed sequentially from $1000.0 in Q4 2024, and down 66.67% YoY from $3000.0 in Q3 2024.
Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025) Analysis & Trends
Akari Therapeutics (AKTX) has 8 years of Interest & Investment Income data on file, last reported at $1000.0 in Q3 2025.
- Quarterly Interest & Investment Income fell 66.67% year-over-year to $1000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 37.5% YoY) and the FY2025 annual result came in at $1000.0, down 87.5% from the prior year.
- Interest & Investment Income steadied at $1000.0 in Q3 2025 per AKTX's latest filing, from $1000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $30000.0 in Q1 2023, with the low at $1000.0 in Q4 2024.
- Average Interest & Investment Income over 3 years is $10111.1, with a median of $3000.0 recorded in 2024.
- Year-over-year, Interest & Investment Income plunged 93.33% in 2024 and tumbled 66.67% in 2025.
- Akari Therapeutics' Interest & Investment Income stood at $7000.0 in 2023, then slumped by 85.71% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- Business Quant data shows AKTX's Interest & Investment Income at $1000.0 in Q3 2025, $1000.0 in Q4 2024, and $3000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | 44.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | - |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 27.66 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 114.80 Mn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | - |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 44.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 26.60 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | 19.51 Mn |
| 10 | Moderna | 28.64 Bn | 23.43 Bn | -566.00 Mn | 72.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2020 | 5,321.00 |
| Sep 30, 2020 | 6,132.00 |
| Jun 30, 2020 | 1,152.00 |
| Mar 31, 2020 | 1,010.00 |
| Dec 31, 2019 | 1,739.00 |
| Sep 30, 2019 | 2,057.00 |
| Jun 30, 2019 | 449.00 |
| Mar 31, 2019 | 1,286.00 |
| Mar 31, 2016 | 30,804.00 |
| Dec 31, 2015 | 19,260.00 |
| Sep 30, 2015 | 1,445.00 |